Restenosis prevention after percutaneous transluminal coronary angioplasty with N-3 fatty acids: Results of the randomized, double-blind, placebo controlled ''ESPRIT'' study.

被引:0
|
作者
Maresta, A
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3630 / 3630
页数:1
相关论文
共 50 条
  • [1] EVALUATION OF KETANSERIN IN THE PREVENTION OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    SERRUYS, PW
    KLEIN, W
    TIJSSEN, JPG
    RUTSCH, W
    HEYNDRICKX, GR
    EMANUELSSON, H
    BALL, SG
    DECOSTER, O
    SCHROEDER, E
    LIBERMAN, H
    EICHHORN, E
    WILLERSON, JT
    ANDERSON, HV
    KHAJA, F
    ALEXANDER, RW
    BAIM, D
    MELKERT, R
    VANOENE, JC
    VANGOOL, R
    CIRCULATION, 1993, 88 (04) : 1588 - 1601
  • [2] PREVENTION OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY WITH THROMBOXANE A2-RECEPTOR BLOCKADE - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    SERRUYS, PW
    RUTSCH, W
    HEYNDRICKX, GR
    DANCHIN, N
    MAST, EG
    WIJNS, W
    RENSING, BJ
    VOS, J
    STIBBE, J
    CIRCULATION, 1991, 84 (04) : 1568 - 1580
  • [3] n-3 fatty acids do not prevent restenosis after coronary angioplasty: Results from the CART study
    Johansen, O
    Brekke, M
    Seljeflot, I
    Abdelnoor, M
    Arnesen, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (06) : 1619 - 1626
  • [4] Prevention of coronary arterial renarrowing by continuous 3-day infusion of tissue plasminogen activator after successful percutaneous transluminal coronary angioplasty: A randomized, double-blind, placebo-controlled study
    Kanamasa, K
    Ogawa, I
    Hayashi, T
    Nakabayashi, T
    Otani, N
    Ishikawa, K
    ANGIOLOGY, 2000, 51 (05) : 367 - 375
  • [5] DOES THE NEW ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR CILAZAPRIL PREVENT RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - RESULTS OF THE MERCATOR STUDY - A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    BALCON, R
    TIMMINS, J
    SPRINGINGS, DC
    BRECKER, SJD
    DAVIES, SW
    BONNET, JL
    DHOUDAIN, F
    BUIS, B
    BAKX, ALM
    SEDNEY, MI
    CAMPOLO, L
    DANZI, GB
    DEBIASE, AM
    CHAPPUIS, F
    RUTISHAUSER, W
    URBAN, P
    MEIER, B
    DANCHIN, N
    JUILLIERE, Y
    VOILQUINTHOMAS, V
    EMANUELSSON, H
    ALBERTSSON, P
    SELIN, K
    EKSTROM, L
    VONESSEN, R
    NEBELSIECK, H
    UBERREITER, A
    IGERL, K
    HEYNDRICKX, GR
    NELLENS, P
    DEBRUYNE, B
    GOETHALS, M
    ISCHINGER, T
    FISCHER, M
    COPPENRATH, K
    JUST, HJ
    WOLLSCHLAGER, H
    DREXLER, H
    ELIAS, G
    KRAYENBUHL, HP
    HESS, O
    AMANN, FW
    SCHLAPFER, R
    BUCHI, M
    KUNKEL, B
    FURSTE, T
    LABLANCHE, JM
    JORIS, JM
    EEMAN, T
    HENRY, M
    CIRCULATION, 1992, 86 (01) : 100 - 110
  • [6] Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study)
    Dens, JA
    Desmet, WJ
    Coussement, P
    De Scheerder, IK
    Kostopoulos, K
    Kerdsinchai, P
    Supanantaroek, C
    Piessens, JH
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (01): : 28 - 33
  • [7] Double-blind placebo controlled trial of N-3 polyunsaturated fatty acids as an adjunct to neuroleptics
    Peet, M
    Mellor, J
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 160 - 161
  • [8] External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: Results of a prospective randomized double-blind study
    Fritz, P
    Stein, U
    Hasslacher, C
    Zierhut, D
    Wannenmacher, M
    Pritsch, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (03): : 815 - 821
  • [9] Clinical response of ulcerative colitis with dietary supplementation by n-3 fatty acids: A double-blind, randomized study.
    Varghese, TJ
    Coomansingh, D
    Richardson, S
    Brunt, PW
    Mowat, NAG
    Eltahir, A
    Eremin, O
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2000, 59 : 160A - 160A
  • [10] RANDOMIZED DOUBLE-BLIND SCANDINAVIAN TRIAL OF ANGIOPEPTIN VERSUS PLACEBO FOR THE PREVENTION OF CLINICAL EVENTS AND RESTENOSIS AFTER CORONARY BALLOON ANGIOPLASTY
    ERIKSEN, UH
    AMTORP, O
    BAGGER, JP
    EMANUELSSON, H
    FOEGH, M
    HENNINGSEN, P
    SAUNAMAKI, K
    SCHAEFFER, M
    THAYSSEN, P
    ORSKOV, H
    KUNTZ, RE
    POPMA, JJ
    AMERICAN HEART JOURNAL, 1995, 130 (01) : 1 - 8